Pegasus 2Lung Perfusion PET/CT for Reduced Radiation Injury in Lung SBRT
Conventional anatomical planning radiotherapy
+ Functional Lung avoidance planning
Disease+7
+ Lung Diseases
+ Lung Neoplasms
Treatment Study
Summary
Study start date: January 15, 2026
Actual date on which the first participant was enrolled.This study focuses on improving the way radiation treatment is planned for patients with lung tumors. It aims to reduce the risk of lung damage that can occur as a side effect of stereotactic body radiotherapy (SBRT), a common treatment for lung cancer. A new imaging technique, 68Ga-MAA lung perfusion PET/CT, is being tested to create a more personalized treatment plan by identifying which parts of the lung are most functional and should be protected during radiation. The goal is to minimize lung injury, which can affect up to 20% of patients, by targeting the radiation more precisely. Participants in this study will undergo SBRT guided by this new imaging method to compare its effectiveness against the traditional planning method that uses anatomical lung images. The study will assess whether this functional planning approach reduces the occurrence of significant lung toxicity, known as radiation-induced lung injury, within a year after treatment. The effects will be measured by a medical oncologist who does not know which treatment plan each participant received, ensuring unbiased results. This research could lead to safer and more effective lung cancer treatments by protecting lung function while still effectively treating the tumor.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.418 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Patients aged \> 18 years planned to be treated in the radiotherapy department of the participating centers with SBRT for primary or secondary lung tumors will be eligible to participate into the study Exclusion Criteria: * Inability to give informed consent * Patientsunder guardianship or curatorship * Pregnant or breastfeeding women. * Contraindications to the radiolabeled product infused for lung perfusion PET/CT.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Centre de Lutte Contre le Cancer Leon Bérard Lyon
Lyon, France